[go: up one dir, main page]

WO2006120360A3 - Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique - Google Patents

Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique Download PDF

Info

Publication number
WO2006120360A3
WO2006120360A3 PCT/FR2006/001079 FR2006001079W WO2006120360A3 WO 2006120360 A3 WO2006120360 A3 WO 2006120360A3 FR 2006001079 W FR2006001079 W FR 2006001079W WO 2006120360 A3 WO2006120360 A3 WO 2006120360A3
Authority
WO
WIPO (PCT)
Prior art keywords
disturbance
prevention
treatment
active composition
biological clock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2006/001079
Other languages
English (en)
Other versions
WO2006120360A2 (fr
Inventor
Jean-Christophe Anton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Persee Medica SAS
Original Assignee
Persee Medica SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Persee Medica SAS filed Critical Persee Medica SAS
Priority to US11/920,013 priority Critical patent/US20090069425A1/en
Priority to CA002608060A priority patent/CA2608060A1/fr
Priority to EA200702479A priority patent/EA200702479A1/ru
Priority to EP06764621A priority patent/EP1879621A2/fr
Publication of WO2006120360A2 publication Critical patent/WO2006120360A2/fr
Publication of WO2006120360A3 publication Critical patent/WO2006120360A3/fr
Anticipated expiration legal-status Critical
Priority to NO20076426A priority patent/NO20076426L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition utile pour traiter ou prévenir les troubles occasionnés par un dérèglement de l'horloge biologique chez l'homme et comprenant à titre d'agents actifs des acides gras polyinsaturés et des flavonoïdes.
PCT/FR2006/001079 2005-05-13 2006-05-12 Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique Ceased WO2006120360A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US11/920,013 US20090069425A1 (en) 2005-05-13 2006-05-12 Active composition for treatment or prevention of problems related to a disturbance of the biological clock
CA002608060A CA2608060A1 (fr) 2005-05-13 2006-05-12 Composition pour traiter ou prevenir les troubles lies a un dereglement de l'horloge biologique
EA200702479A EA200702479A1 (ru) 2005-05-13 2006-05-12 Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов
EP06764621A EP1879621A2 (fr) 2005-05-13 2006-05-12 Composition pour traiter ou prevenir les troubles liés a un dérèglement d'horloge biologique
NO20076426A NO20076426L (no) 2005-05-13 2007-12-13 Aktiv sammensetning for behandling eller for a unnga problemer relatert til forstyrrelse av den biologiske klokken

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0551254A FR2885528A1 (fr) 2005-05-13 2005-05-13 Composition utile pour traiter ou prevenir les troubles lies a un dereglement de l'horloge biologique
FR0551254 2005-05-13

Publications (2)

Publication Number Publication Date
WO2006120360A2 WO2006120360A2 (fr) 2006-11-16
WO2006120360A3 true WO2006120360A3 (fr) 2007-11-08

Family

ID=35423717

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2006/001079 Ceased WO2006120360A2 (fr) 2005-05-13 2006-05-12 Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique

Country Status (7)

Country Link
US (1) US20090069425A1 (fr)
EP (1) EP1879621A2 (fr)
CA (1) CA2608060A1 (fr)
EA (1) EA200702479A1 (fr)
FR (1) FR2885528A1 (fr)
NO (1) NO20076426L (fr)
WO (1) WO2006120360A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3485894T (lt) * 2017-11-20 2021-04-26 Italfarmaco Spa Vaistinių augalų derinys ir jų naudojimas miego sutrikimų gydymui ir (arba) prevencijai
JP2020031570A (ja) * 2018-08-29 2020-03-05 大正製薬株式会社 体内時計調整用組成物

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275643A1 (fr) * 1986-11-26 1988-07-27 Bar Ilan University Composition physiologiquement active et alimentaire
WO2002030404A2 (fr) * 2000-10-12 2002-04-18 Bioriginal Food & Science Corporation Therapie combinee destinee aux symptomes premenstruels
WO2002032234A1 (fr) * 2000-10-17 2002-04-25 Laboratoires Robert Schwartz Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
US6391346B1 (en) * 2001-04-05 2002-05-21 Thomas Newmark Anti-inflammatory, sleep-promoting herbal composition and method of use
WO2003037360A1 (fr) * 2001-10-30 2003-05-08 Rongxiang Xu Methode permettant de reparer la muqueuse du tractus gastro-intestinal ainsi que d'en stimuler la regeneration et composition a cet effet
DE10255481A1 (de) * 2002-11-28 2004-06-17 Dr. Loges + Co. Gmbh Arzneimittel Pharmazeutische Zubereitungen umfassend mittels Extraktion mit überkritischen Flüssigkeiten hergestellte Hopfenextrakte zur Verwendung als Sedativa
WO2004087181A2 (fr) * 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Combinaisons de principes actifs d'huiles contenant des acides gras $g(v)3 avec des extraits vegetaux contenant des polyphenols et utilisation desdites combinaisons

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258922B2 (en) * 2003-03-31 2007-08-21 Thi International, Inc. Compositions, methods and devices for enhancing landscaping or marker materials

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275643A1 (fr) * 1986-11-26 1988-07-27 Bar Ilan University Composition physiologiquement active et alimentaire
WO2002030404A2 (fr) * 2000-10-12 2002-04-18 Bioriginal Food & Science Corporation Therapie combinee destinee aux symptomes premenstruels
WO2002032234A1 (fr) * 2000-10-17 2002-04-25 Laboratoires Robert Schwartz Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
US6391346B1 (en) * 2001-04-05 2002-05-21 Thomas Newmark Anti-inflammatory, sleep-promoting herbal composition and method of use
WO2003037360A1 (fr) * 2001-10-30 2003-05-08 Rongxiang Xu Methode permettant de reparer la muqueuse du tractus gastro-intestinal ainsi que d'en stimuler la regeneration et composition a cet effet
DE10255481A1 (de) * 2002-11-28 2004-06-17 Dr. Loges + Co. Gmbh Arzneimittel Pharmazeutische Zubereitungen umfassend mittels Extraktion mit überkritischen Flüssigkeiten hergestellte Hopfenextrakte zur Verwendung als Sedativa
WO2004087181A2 (fr) * 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Combinaisons de principes actifs d'huiles contenant des acides gras $g(v)3 avec des extraits vegetaux contenant des polyphenols et utilisation desdites combinaisons

Also Published As

Publication number Publication date
NO20076426L (no) 2008-02-08
EA200702479A1 (ru) 2008-04-28
CA2608060A1 (fr) 2006-11-16
EP1879621A2 (fr) 2008-01-23
FR2885528A1 (fr) 2006-11-17
WO2006120360A2 (fr) 2006-11-16
US20090069425A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
WO2007008586A3 (fr) Acides gras polyinsatures pour le traitement de la demence et d'etats predementiels
WO2007087244A3 (fr) Composition détergentes
WO2007087259A3 (fr) Compositions contenant une enzyme et un agent de photoblanchiment
WO2009107091A3 (fr) Composition de détergent contenant une lipase
WO2006105306A3 (fr) Compositions renfermant des acides gras et/ou leurs derives et un stabilisateur a basse temperature
FR2892623B1 (fr) Composition cosmetique comprenant un cation, un corps gras solide et un ester de sorbitan et procede de traitement cosmetique
WO2007141392A3 (fr) Compositions comprenant de l'acide bétulonique
IL190646A (en) Multifunctional June Liquid Preparations, Including Pharmaceutical, Bioactive, Nutritional and Energetic Vehicles and Method for Preparing
WO2007087257A3 (fr) Compositions contenant une enzyme et un agent de teinture de tissus
WO2005120524A3 (fr) Formulations nutritionnelles
WO2008023266A3 (fr) Extrait de kiwi
EP2218342A3 (fr) Nouvelles compositions nutraceutiques et utilisations
ZA200802457B (en) Method for extending the shelf-life of food compositions containing polyunsaturated fatty acids
WO2007002837A3 (fr) Procedes et compositions pour la prevention et le traitement de maladie inflammatoire
WO2007077260A8 (fr) Formules de faible teneur en huile comprenant des dérivés de diphénylméthane
WO2007133721A3 (fr) Compositions alimentaires et procédés de traitement de maladie parodontale
WO2008002121A3 (fr) Support pharmaceutique efficace pour des médicaments faiblement biodisponibles
WO2007121124A3 (fr) Composés organiques et leurs utilisations
LT2100508T (lt) Augalų ligų kontrolės kompozicija ir būdas skirtas augalų ligų prevencijai ir kontrolei
EP1954126A4 (fr) Melanges d'esters d'acides gras en tant que vehicules pour des principes actifs pesticides
WO2006109194A3 (fr) Composes de chrome et d'acides gras et leurs procedes de fabrication et d'utilisation
WO2009038095A1 (fr) Composition comprenant de la sésamine et de la vitamine b1
WO2008011178A3 (fr) Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente
ATE416011T1 (de) Aktivierter citrusschalenextrakt
WO2006103638A3 (fr) Compositions pharmaceutiques topiques de terbinafine et processus de preparation desdites compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006764621

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2608060

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 200702479

Country of ref document: EA

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Ref document number: RU

WWE Wipo information: entry into national phase

Ref document number: 11920013

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006764621

Country of ref document: EP